Peptide Central
What BPC-157 is as a listed laboratory material: sequence, synthetic origin, salt and format variants, reported stability, and what the published evidence base does and does not establish.
This page concerns the catalogue identity of BPC-157 as a laboratory material and the boundaries of what published evidence and batch analysis establish. It is not a treatment guide, a recommendation, a human-use protocol or evidence that the material is safe or effective in people or animals.
BPC-157 is a synthetic pentadecapeptide — a chain of fifteen amino acids. Its sequence corresponds to a partial sequence described in published work on a protein isolated from gastric juice, which is where the "body protection compound" abbreviation originates.
Two points of identity follow:
The listed material is BPC-157, which also appears in the tissue signalling collection.
A peptide can be supplied as different salt forms, and the salt form is part of the material's identity rather than a packaging detail. Arginate salt presentations are listed and described separately from acetate presentations where both are offered, because the counter-ion differs and the stated mass may or may not be corrected for it.
When comparing listed quantities, check whether a figure refers to peptide content or to total salt mass, and whether the batch report states which convention it uses. A 5mg and a 10mg listing of the same peptide differ in supplied quantity, not in identity.
Resistance to degradation in acidic conditions is the physicochemical property most often cited for this peptide, and it is a measurable property of the molecule rather than a claim about an effect. Figures reported for persistence in biological matrices come overwhelmingly from animal models and in-vitro systems, and are specific to the conditions, species and assay used. They are not human pharmacokinetic values and should not be quoted as such.
Published findings must be read according to the model that produced them:
For BPC-157 the published record sits almost entirely in the first two tiers. A substantial preclinical literature exists; a correspondingly substantial human literature does not. Presenting rodent findings in language that implies a demonstrated human outcome misrepresents the source.
BPC-157 is not a licensed medicine in the United Kingdom. It is not authorised for human or veterinary administration, and it is supplied here as a research reagent only. Material offered as a research reagent is outside the licensing framework that governs medicines, which is precisely why the laboratory-use boundary below is a condition of supply rather than a disclaimer attached to it.
A certificate of analysis provides evidence about the particular batch tested — its identity, measured composition and purity by the stated method. It does not establish a biological, therapeutic or physiological outcome, and it does not extend to other batches.
Check the full material name and SKU, the supplied quantity and physical form, the batch number, whether a report exists for that same batch, and the method, laboratory, date and stated limitations of that report. Available reports are published in our COA library; the guides to reading a peptide COA and understanding HPLC purity explain what those documents can and cannot show.
Materials sold on this site are supplied solely for non-clinical in-vitro laboratory research. They must not be ingested, injected, inhaled, applied or otherwise administered to a human or animal.
We do not provide dosing, routes of administration, treatment guidance, cosmetic-use guidance or in-vivo protocols. Preparation, storage and handling must follow a validated institutional SOP, the material documentation and an appropriate risk assessment.
GHK-Cu is a copper-bound tripeptide, and "copper peptide" is a generic term covering several distinct molecules. A non-clinical reference on identity, the copper complex and evidence tiers.
Research DocumentationA non-clinical reference on catalogue identity, analytical documentation and the limits of what published evidence and batch testing establish.
Site materials are supplied solely for non-clinical in-vitro laboratory research. They must not be used in or on humans or animals. We do not provide dosing, routes of administration, treatment, cosmetic-use or in-vivo guidance. Read the legal and research-use terms.
